Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2-Reference-Cited by-同舟云学术

Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2

Published:2000-09 Issue:3 Volume:6 Page:693-704
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Schwaller Juerg,Parganas Evan,Wang Demin,Cain Danielle,Aster Jon C.,Williams Ifor R.,Lee Chien-Kuo,Gerthner Rachel,Kitamura Toshio,Frantsve Julie,Anastasiadou Ema,Loh Mignon L.,Levy David E.,Ihle James N.,Gilliland D.Gary

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference57 articles.

1. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis;Amarante-Mendes;Oncogene,1998

2. Stat3 as an oncogene;Bromberg;Cell,1999

3. Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M;Brown;Blood,1993

4. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl;Carlesso;J. Exp. Med,1996

5. Constitutive activation of JAKs and STATs in BCR/ABL-expressing cell lines and peripheral blood cells derived from leukemic patients;Chai;J. Immunol,1997

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship;Bioorganic Chemistry;2024-11

2. JAK/STAT in leukemia: a clinical update;Molecular Cancer;2024-01-26

3. Transcription Factors in Cancer;Molecular Targets and Cancer Therapeutics (Part 1);2023-04-18

4. Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1‐Runx1 complexes;The EMBO Journal;2023-03-14

5. The combination of ruxolitinib and Bcl-2/Mcl-1 inhibitors has a synergistic effect on leukemic cells carrying a SPAG9::JAK2 fusion;Cancer Gene Therapy;2022-07-25